Taysha Gene Therapies
TSHA
TSHA
86 hedge funds and large institutions have $231M invested in Taysha Gene Therapies in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
+24
Holders Change %
+38.71%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
32
Increased
29
Reduced
11
Closed
8
Calls
$259K
Puts
$61K
Net Calls
+$198K
Net Calls Change
+$76K
Top Buyers
1 |
Millennium Management
New York
|
$5.98M |
2 |
Citadel Advisors
Miami,
Florida
|
$4.07M |
3 |
TCM
Tybourne Capital Management
Hong Kong
|
$6.55M |
4 |
EP
Eversept Partners
New York
|
$6.69M |
5 |
BlackRock
New York
|
$4.78M |